AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.705
+0.025 (0.93%)
Dec 26, 2024, 4:00 PM EST - Market closed

AC Immune Revenue

AC Immune had revenue of 25.49M CHF in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to 40.97M, up 4,097,200.00% year-over-year. In the year 2023, AC Immune had annual revenue of 14.80M with 276.14% growth.

Revenue (ttm)
40.97M CHF
Revenue Growth
+4,097,200.00%
P/S Ratio
5.33
Revenue / Employee
254,491 CHF
Employees
161
Market Cap
267.63M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019110.46M103.54M1,498.03%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.